It has also clarified that only stock data with a three- month lag can now be used, thus effectively preventing real-time ...

Sebi’s regulations regarding preferential treatment of large investors pose a dilemma to private equity (PE) and venture ...

Kikkoman has a solid balance sheet, in our view, as the company sits on strong cash balance with minimal debt. The company’s debt/equity ratio is lower than domestic and international peers, following ...

B-Team's Chris Wojcik is back to share how you can approach your training in a way that really maximizes your time ...

January 31, 2025 expert reaction to NICE final draft guidance on exagamglogene autotemcel (exa-cel) for severe sickle cell disease . Scientists comment on final draft guidance fro ...

Located in a conservation shophouse on Mohammed Sultan Road, Esora—meaning painting in the sky—is a modern ... Another irresistible seasonal signature is the Ise Ebi Sashimi, pristine raw lobster tail ...

Drugmaker Abbott India reported a jump in third-quarter profit on Wednesday, helped by strong demand for its gastrointestinal ...

JK-TYRE-IND-RESULTS:India’s JK Tyre posts second straight drop in profit on weak demand from bus, truck makers ...

India's Zydus Lifesciences reported third-quarter profit above analysts' expectations on Wednesday, driven by strong demand for its generic drugs in its key U.S. market. The drugmaker's consolidated ...

India's J B Chemicals & Pharmaceuticals reported a bigger third-quarter profit on Tuesday, helped by sustained domestic demand for its drugs for chronic and acute conditions. The drugmaker's ...

Indian generic injectables maker Gland Pharma reported a 7% rise in third-quarter profit on Monday, as lower expenses helped mitigate the impact from production issues at its French unit ...